Firm at a glance
Town Hall Ventures is a venture capital firm that closed its fourth fund in October 2025, per public sources [S1].
What they buy
Based on publicly reported transactions, Town Hall Ventures appears to focus on healthcare technology and digital health companies. The firm’s recent investments span medical liability insurance technology, patient record platforms, home healthcare services, AI-enabled clinical tools, and assistive robotics for healthcare applications [S2][S3][S4][S5][S6]. This pattern suggests a thesis centered on technology-enabled healthcare delivery and infrastructure.
Portfolio
Public sources identify the following investments made by Town Hall Ventures:
**Healthcare Technology**
– Indigo (medical liability insurer, February 2026) [S4]
– Kin Health (patient care record platform, May 2026) [S6]
– House Rx (home healthcare services, November 2025) [S2]
– Ambience Healthcare (AI healthcare platform, August 2025) [S3]
– Tombot (assistive robotics, July 2025) [S5]
Recent activity (last 24 months)
– May 2026: Participated in Kin Health’s $9 million funding round [S6]
– February 2026: Joined $50 million Series B for medical liability insurer Indigo [S4]
– November 2025: Invested in House Rx’s $55 million Series B [S2]
– October 2025: Closed Town Hall Ventures Fund IV [S1]
– August 2025: Participated in Ambience Healthcare’s $243 million Series C [S3]
– July 2025: Invested in Tombot [S5]
How this firm fits a seller
Town Hall Ventures appears positioned for venture-stage healthcare technology companies rather than traditional buyouts of established businesses. The firm’s observed activity involves growth equity rounds in companies building software, AI platforms, and technology-enabled services for the healthcare sector. Sellers seeking venture capital for scaling digital health or healthcare IT businesses may find alignment, particularly those addressing clinical workflow, insurance technology, or patient engagement. The firm’s recent fund close in October 2025 suggests active deployment capacity as of that date [S1].
Sources
[S1] https://medcitynews.com/2025/10/venture-capital-investment-ai-healthcare/ (as of 2025-10)
[S2] https://www.wsgr.com/en/insights/wilson-sonsini-advises-house-rx-on-dollar55-million-series-b.html (as of 2025-11)
[S3] https://www.thesaasnews.com/news/ambience-healthcare-raises-243m-in-series-c/ (as of 2025-08)
[S4] https://www.citybiz.co/article/801378/town-hall-ventures-joins-50m-series-b-for-medical-liability-insurer-indigo/ (as of 2026-02)
[S5] https://www.fiercehealthcare.com/health-tech/fierce-healthcare-fundraising-tracker-3 (as of 2025-07)
[S6] https://www.businesswire.com/news/home/20260518890468/en/Kin-Health-Raises-%249M-To-Give-Patients-a-Record-of-Their-Own-Care (as of 2026-05)
Frequently asked questions
Does Town Hall Ventures buy healthcare businesses?
Town Hall Ventures invests in healthcare technology companies, with publicly reported transactions including medical liability insurance platforms, patient record systems, home healthcare services, and AI clinical tools [S2][S3][S4][S6]. The firm appears focused on venture and growth equity rather than traditional acquisitions of established healthcare providers.
What companies has Town Hall Ventures acquired recently?
Recent publicly reported investments include Kin Health (patient care records, May 2026), Indigo (medical liability insurance, February 2026), and House Rx (home healthcare, November 2025) [S2][S4][S6]. These represent equity investments in growth-stage companies rather than full acquisitions.
Where is Town Hall Ventures based and how big is the firm?
Public sources confirm the firm closed its fourth fund in October 2025 [S1]. Headquarters location and fund size were not disclosed in available public materials as of the dates cited.
Is Town Hall Ventures still actively acquiring?
The firm’s most recent publicly reported investment occurred in May 2026 with Kin Health’s $9 million funding round [S6], and it closed Fund IV in October 2025 [S1], suggesting active deployment as of mid-2026.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.